Saturday, November 13, 2021 3:12:44 PM
To longs
I found it very comforting to watch the video where LP introduced Dr Bosch, who presented the blinded data, and then each of about 5 dcvax recipients (or a family member) spoke about their very terminal diagnoses and how dcvax gave them much extended lives with normal quality of life! The doctor who is the lead investigator in the UK spoke about what he has been seeing clinically and how he wants dcvax available ASAP.
Patients who were given 3 - 18 months in no uncertain terms were healthy and alive 5 - 12+ years post prognosis!!!!!
That’s what it’s all about folks. And while I can be fooled, I’m more often a good judge of character and LP came across as sincere and even momentarily passionate about getting dcvax to patients at an approachable price.
LP also spoke to the possible means to achieve lower costs, including closed system and process automation. LP is the real deal IMHO !!!
I found it very comforting to watch the video where LP introduced Dr Bosch, who presented the blinded data, and then each of about 5 dcvax recipients (or a family member) spoke about their very terminal diagnoses and how dcvax gave them much extended lives with normal quality of life! The doctor who is the lead investigator in the UK spoke about what he has been seeing clinically and how he wants dcvax available ASAP.
Patients who were given 3 - 18 months in no uncertain terms were healthy and alive 5 - 12+ years post prognosis!!!!!
That’s what it’s all about folks. And while I can be fooled, I’m more often a good judge of character and LP came across as sincere and even momentarily passionate about getting dcvax to patients at an approachable price.
LP also spoke to the possible means to achieve lower costs, including closed system and process automation. LP is the real deal IMHO !!!
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
